media – Page 637 – DrugDu- Global Leading Pharmaceutical & Medical Device Platform

Researchers develop digestible sensors for monitoring the gastrointestinal tract

MIT’s researchers spend a lot of time thinking about digestible technology. In the past couple of years, scientists at the school have developed all sorts of swallowable devices, including a robot fashioned from pig parts designed to remove batteries. The school's Koch Institute in particular has focused on the space, looking at ways in which digestible sensors can be used to monitor things like drug intake.
- Source: techcrunch
- 654
- October 24, 2017
digestible sensor gastrointestinal tract MIT Researches
KU Leuven researchers identify new rapid response mechanism against bacterial infections

When bacteria enter our body, they kick-start a powerful immune response. But this chain of reactions doesn't fully account for our immediate responses. Researchers at KU Leuven, Belgium, show that so-called ion channels play a key role as 'first responders'.
- Source: news-medical
- 611
- October 24, 2017
bacteria immune infections
Ebola vaccine wins approval from regulators

China's top food and drug authority announced on Friday that it has approved the country's first vaccine for Ebola virus disease.
- Source: Chinadaily
- 727
- October 23, 2017
CFDA Ebola New Approvals
Shingrix approved in the US for prevention of shingles in adults aged 50 and over

GlaxoSmithKline plc announced that the US Food and Drug Administration (FDA) has approved Shingrix (Zoster Vaccine Recombinant, Adjuvanted) for the prevention of shingles (herpes zoster) in adults aged 50 years and older. Shingrix is a non-live, recombinant subunit vaccine given intramuscularly in two doses.
- Source: Gsk
- 629
- October 23, 2017
FDA New Approvals shingles vaccine
AbbVie and Harpoon Therapeutics Announce Immuno-Oncology Research Collaboration

"This collaboration is the first for Harpoon and highlights the high level of industry interest in best-in-class platform technologies. We are excited about partnering with AbbVie to help generate novel T-cell engagers for the treatment of cancer based on the combination of T-cell receptors with TriTACs," said Jerry McMahon, Ph.D., chief executive officer, Harpoon Therapeutics.
- Source: finance.yahoo
- 690
- October 23, 2017
AbbVie Market Views T-cell recruiting biologic
Britain backs GSK’s gene therapy for ‘bubble boy’ syndrome

Gene therapy is designed to deliver a one-off cure for the patient and drugmakers are typically asking a hefty price that is comparable to the combined costs of alternative life-long treatment.
- Source: reuters
- 830
- October 23, 2017
ADA-SCID Company Insight gene Market Views NICE
Drug delivery devices market in India to reach $510m by 2023

The drug delivery devices market in India is expected to rise at a compound annual growth (CAGR) of 3.1% from $411m in 2016 to $510m by 2023, according to a report by GlobalData.
- Source: medicaldevice-network
- 399
- October 23, 2017
drug delivery devices India Market Views
‘Handful of changes’ make cancer

British scientists have worked out how many changes it takes to transform a healthy cell into a cancer.
- Source: bbc
- 813
- October 23, 2017
cancer herceptin inhibitor tumour
China to adjust registration management for drugs and medical devices

To promote the adjustment of industrial structure and technological innovation in the drug and medical device sector, the Communist Party of China’s Central Committee and the State Council jointly released a guideline on the reform of the review and approval system, which came into effect on October 8, 2017.
- Source: china-briefing
- 1,201
- October 23, 2017
CFDA drug medical device Policy
Guidance for Visiting Foreign Clients (Ⅰ)

In the age of e-commerce, there are multiple ways to develop potential client relationships online but site visits have been proven to be the most effective method. Nowadays, many forward-thinking companies are going global with great achievements but, in contrast to these early adopters, there are those companies who are still waiting on the sidelines, mostly due to a lack of expertise and experience. This is why Ddu has prepared a list of our tried and trusted methods for visiting and dealing with foreign clients.
- Source: Ddu
- 1,211
- October 20, 2017
clients Ddu College

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.